Supply Security And Competitive Pricing Will Support Byooviz Launch In US
Samsung Bioepis And Biogen Executives Discuss Newly Introduced Lucentis Biosimilar
Byooviz represents the first US biosimilar with ophthalmic indications • Source: Shutterstock